1c8l: Difference between revisions

From Proteopedia
Jump to navigationJump to search
← Older editNewer edit →
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,330,058 edits
No edit summary
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,330,058 edits
No edit summary
Line 1: Line 1:
[[Image:1c8l.gif|left|200px]]
{{Seed}}
[[Image:1c8l.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1c8l|  PDB=1c8l  |  SCENE=  }}  
{{STRUCTURE_1c8l|  PDB=1c8l  |  SCENE=  }}  


'''SYNERGISTIC INHIBITION OF GLYCOGEN PHOSPHORYLASE A BY A POTENTIAL ANTIDIABETIC DRUG AND CAFFEINE'''
===SYNERGISTIC INHIBITION OF GLYCOGEN PHOSPHORYLASE A BY A POTENTIAL ANTIDIABETIC DRUG AND CAFFEINE===




==Overview==
<!--
Caffeine, an allosteric inhibitor of glycogen phosphorylase a (GPa), has been shown to act synergistically with the potential antidiabetic drug (-)(S)-3-isopropyl 4-(2-chlorophenyl)-1,4-dihydro-1-ethyl-2-methyl-pyridine-3,5,6-tricarboxyl ate (W1807). The structure of GPa complexed with caffeine and W1807 has been determined at 100K to 2.3 A resolution, and refined to a crystallographic R value of 0.210 (Rfree = 0.257). The complex structure provides a rationale to understand the structural basis of the synergistic inhibition between W1807 and caffeine. W1807 binds tightly at the allosteric site, and induces substantial conformational changes both in the vicinity of the allosteric site and the subunit interface which transform GPa to the T'-like state conformation already observed with GPa-glucose-W1807 complex. A disordering of the N-terminal tail occurs, while the loop of polypeptide chain containing residues 192-196 and residues 43'-49', from the symmetry related subunit, shift to accommodate W1807. Caffeine binds at the purine inhibitor site by intercalating between the two aromatic rings of Phe285 and Tyr613 and stabilises the location of the 280s loop in the T state conformation.
The line below this paragraph, {{ABSTRACT_PUBMED_11368311}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 11368311 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_11368311}}


==About this Structure==
==About this Structure==
Line 32: Line 36:
[[Category: Phosphorylase some]]
[[Category: Phosphorylase some]]
[[Category: Synergistic inhibition]]
[[Category: Synergistic inhibition]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May  2 12:27:44 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jun 30 20:22:01 2008''

Revision as of 17:22, 30 June 2008

File:1c8l.png

Template:STRUCTURE 1c8l

SYNERGISTIC INHIBITION OF GLYCOGEN PHOSPHORYLASE A BY A POTENTIAL ANTIDIABETIC DRUG AND CAFFEINE

Template:ABSTRACT PUBMED 11368311

About this Structure

1C8L is a Single protein structure of sequence from Oryctolagus cuniculus. Full crystallographic information is available from OCA.

Reference

Structural basis of the synergistic inhibition of glycogen phosphorylase a by caffeine and a potential antidiabetic drug., Tsitsanou KE, Skamnaki VT, Oikonomakos NG, Arch Biochem Biophys. 2000 Dec 15;384(2):245-54. PMID:11368311

Page seeded by OCA on Mon Jun 30 20:22:01 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "https://proteopedia.org/index.php?title=1c8l&oldid=581459"